IBDEI217 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,32424,1,4,0)
;;=4^H35.373
;;^UTILITY(U,$J,358.3,32424,2)
;;=^5005664
;;^UTILITY(U,$J,358.3,32425,0)
;;=H35.33^^128^1660^22
;;^UTILITY(U,$J,358.3,32425,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32425,1,3,0)
;;=3^Angioid Streaks of Macula
;;^UTILITY(U,$J,358.3,32425,1,4,0)
;;=4^H35.33
;;^UTILITY(U,$J,358.3,32425,2)
;;=^5005649
;;^UTILITY(U,$J,358.3,32426,0)
;;=H35.711^^128^1660^7
;;^UTILITY(U,$J,358.3,32426,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32426,1,3,0)
;;=3^Central Serous Chorioretinopathy,OD
;;^UTILITY(U,$J,358.3,32426,1,4,0)
;;=4^H35.711
;;^UTILITY(U,$J,358.3,32426,2)
;;=^5005703
;;^UTILITY(U,$J,358.3,32427,0)
;;=H35.712^^128^1660^8
;;^UTILITY(U,$J,358.3,32427,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32427,1,3,0)
;;=3^Central Serous Chorioretinopathy,OS
;;^UTILITY(U,$J,358.3,32427,1,4,0)
;;=4^H35.712
;;^UTILITY(U,$J,358.3,32427,2)
;;=^5005704
;;^UTILITY(U,$J,358.3,32428,0)
;;=H35.713^^128^1660^9
;;^UTILITY(U,$J,358.3,32428,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32428,1,3,0)
;;=3^Central Serous Chorioretinopathy,Bilateral
;;^UTILITY(U,$J,358.3,32428,1,4,0)
;;=4^H35.713
;;^UTILITY(U,$J,358.3,32428,2)
;;=^5005705
;;^UTILITY(U,$J,358.3,32429,0)
;;=H35.421^^128^1660^19
;;^UTILITY(U,$J,358.3,32429,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32429,1,3,0)
;;=3^Microcystoid Degeneration or Retina,OD
;;^UTILITY(U,$J,358.3,32429,1,4,0)
;;=4^H35.421
;;^UTILITY(U,$J,358.3,32429,2)
;;=^5005675
;;^UTILITY(U,$J,358.3,32430,0)
;;=H35.422^^128^1660^20
;;^UTILITY(U,$J,358.3,32430,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32430,1,3,0)
;;=3^Microcystoid Degeneration or Retina,OS
;;^UTILITY(U,$J,358.3,32430,1,4,0)
;;=4^H35.422
;;^UTILITY(U,$J,358.3,32430,2)
;;=^5005676
;;^UTILITY(U,$J,358.3,32431,0)
;;=H35.423^^128^1660^21
;;^UTILITY(U,$J,358.3,32431,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32431,1,3,0)
;;=3^Microcystoid Degeneration or Retina,Bilateral
;;^UTILITY(U,$J,358.3,32431,1,4,0)
;;=4^H35.423
;;^UTILITY(U,$J,358.3,32431,2)
;;=^5005677
;;^UTILITY(U,$J,358.3,32432,0)
;;=H35.451^^128^1660^23
;;^UTILITY(U,$J,358.3,32432,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32432,1,3,0)
;;=3^Secondary Pigmentary Degeneration,OD
;;^UTILITY(U,$J,358.3,32432,1,4,0)
;;=4^H35.451
;;^UTILITY(U,$J,358.3,32432,2)
;;=^5005687
;;^UTILITY(U,$J,358.3,32433,0)
;;=H35.452^^128^1660^24
;;^UTILITY(U,$J,358.3,32433,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32433,1,3,0)
;;=3^Secondary Pigmentary Degeneration,OS
;;^UTILITY(U,$J,358.3,32433,1,4,0)
;;=4^H35.452
;;^UTILITY(U,$J,358.3,32433,2)
;;=^5005688
;;^UTILITY(U,$J,358.3,32434,0)
;;=H35.453^^128^1660^25
;;^UTILITY(U,$J,358.3,32434,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32434,1,3,0)
;;=3^Secondary Pigmentary Degeneration,Bilateral
;;^UTILITY(U,$J,358.3,32434,1,4,0)
;;=4^H35.453
;;^UTILITY(U,$J,358.3,32434,2)
;;=^5005689
;;^UTILITY(U,$J,358.3,32435,0)
;;=H35.381^^128^1660^16
;;^UTILITY(U,$J,358.3,32435,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32435,1,3,0)
;;=3^Toxic Maculopathy,OD
;;^UTILITY(U,$J,358.3,32435,1,4,0)
;;=4^H35.381
;;^UTILITY(U,$J,358.3,32435,2)
;;=^5005666
;;^UTILITY(U,$J,358.3,32436,0)
;;=H35.382^^128^1660^17
;;^UTILITY(U,$J,358.3,32436,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32436,1,3,0)
;;=3^Toxic Maculopathy,OS
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI217 3748 printed Apr 09, 2024@21:14:53 Page 2
IBDEI217 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,32424,1,4,0)
+2 ;;=4^H35.373
+3 ;;^UTILITY(U,$J,358.3,32424,2)
+4 ;;=^5005664
+5 ;;^UTILITY(U,$J,358.3,32425,0)
+6 ;;=H35.33^^128^1660^22
+7 ;;^UTILITY(U,$J,358.3,32425,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,32425,1,3,0)
+10 ;;=3^Angioid Streaks of Macula
+11 ;;^UTILITY(U,$J,358.3,32425,1,4,0)
+12 ;;=4^H35.33
+13 ;;^UTILITY(U,$J,358.3,32425,2)
+14 ;;=^5005649
+15 ;;^UTILITY(U,$J,358.3,32426,0)
+16 ;;=H35.711^^128^1660^7
+17 ;;^UTILITY(U,$J,358.3,32426,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,32426,1,3,0)
+20 ;;=3^Central Serous Chorioretinopathy,OD
+21 ;;^UTILITY(U,$J,358.3,32426,1,4,0)
+22 ;;=4^H35.711
+23 ;;^UTILITY(U,$J,358.3,32426,2)
+24 ;;=^5005703
+25 ;;^UTILITY(U,$J,358.3,32427,0)
+26 ;;=H35.712^^128^1660^8
+27 ;;^UTILITY(U,$J,358.3,32427,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,32427,1,3,0)
+30 ;;=3^Central Serous Chorioretinopathy,OS
+31 ;;^UTILITY(U,$J,358.3,32427,1,4,0)
+32 ;;=4^H35.712
+33 ;;^UTILITY(U,$J,358.3,32427,2)
+34 ;;=^5005704
+35 ;;^UTILITY(U,$J,358.3,32428,0)
+36 ;;=H35.713^^128^1660^9
+37 ;;^UTILITY(U,$J,358.3,32428,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,32428,1,3,0)
+40 ;;=3^Central Serous Chorioretinopathy,Bilateral
+41 ;;^UTILITY(U,$J,358.3,32428,1,4,0)
+42 ;;=4^H35.713
+43 ;;^UTILITY(U,$J,358.3,32428,2)
+44 ;;=^5005705
+45 ;;^UTILITY(U,$J,358.3,32429,0)
+46 ;;=H35.421^^128^1660^19
+47 ;;^UTILITY(U,$J,358.3,32429,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,32429,1,3,0)
+50 ;;=3^Microcystoid Degeneration or Retina,OD
+51 ;;^UTILITY(U,$J,358.3,32429,1,4,0)
+52 ;;=4^H35.421
+53 ;;^UTILITY(U,$J,358.3,32429,2)
+54 ;;=^5005675
+55 ;;^UTILITY(U,$J,358.3,32430,0)
+56 ;;=H35.422^^128^1660^20
+57 ;;^UTILITY(U,$J,358.3,32430,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,32430,1,3,0)
+60 ;;=3^Microcystoid Degeneration or Retina,OS
+61 ;;^UTILITY(U,$J,358.3,32430,1,4,0)
+62 ;;=4^H35.422
+63 ;;^UTILITY(U,$J,358.3,32430,2)
+64 ;;=^5005676
+65 ;;^UTILITY(U,$J,358.3,32431,0)
+66 ;;=H35.423^^128^1660^21
+67 ;;^UTILITY(U,$J,358.3,32431,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,32431,1,3,0)
+70 ;;=3^Microcystoid Degeneration or Retina,Bilateral
+71 ;;^UTILITY(U,$J,358.3,32431,1,4,0)
+72 ;;=4^H35.423
+73 ;;^UTILITY(U,$J,358.3,32431,2)
+74 ;;=^5005677
+75 ;;^UTILITY(U,$J,358.3,32432,0)
+76 ;;=H35.451^^128^1660^23
+77 ;;^UTILITY(U,$J,358.3,32432,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,32432,1,3,0)
+80 ;;=3^Secondary Pigmentary Degeneration,OD
+81 ;;^UTILITY(U,$J,358.3,32432,1,4,0)
+82 ;;=4^H35.451
+83 ;;^UTILITY(U,$J,358.3,32432,2)
+84 ;;=^5005687
+85 ;;^UTILITY(U,$J,358.3,32433,0)
+86 ;;=H35.452^^128^1660^24
+87 ;;^UTILITY(U,$J,358.3,32433,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,32433,1,3,0)
+90 ;;=3^Secondary Pigmentary Degeneration,OS
+91 ;;^UTILITY(U,$J,358.3,32433,1,4,0)
+92 ;;=4^H35.452
+93 ;;^UTILITY(U,$J,358.3,32433,2)
+94 ;;=^5005688
+95 ;;^UTILITY(U,$J,358.3,32434,0)
+96 ;;=H35.453^^128^1660^25
+97 ;;^UTILITY(U,$J,358.3,32434,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,32434,1,3,0)
+100 ;;=3^Secondary Pigmentary Degeneration,Bilateral
+101 ;;^UTILITY(U,$J,358.3,32434,1,4,0)
+102 ;;=4^H35.453
+103 ;;^UTILITY(U,$J,358.3,32434,2)
+104 ;;=^5005689
+105 ;;^UTILITY(U,$J,358.3,32435,0)
+106 ;;=H35.381^^128^1660^16
+107 ;;^UTILITY(U,$J,358.3,32435,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,32435,1,3,0)
+110 ;;=3^Toxic Maculopathy,OD
+111 ;;^UTILITY(U,$J,358.3,32435,1,4,0)
+112 ;;=4^H35.381
+113 ;;^UTILITY(U,$J,358.3,32435,2)
+114 ;;=^5005666
+115 ;;^UTILITY(U,$J,358.3,32436,0)
+116 ;;=H35.382^^128^1660^17
+117 ;;^UTILITY(U,$J,358.3,32436,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,32436,1,3,0)
+120 ;;=3^Toxic Maculopathy,OS
